| Astrazeneca Pharma India Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 506820 |
NSE Symbol : ASTRAZEN |
P/E(TTM) : 99.62 |
|
ISIN Demat : INE203A01020 |
Div & Yield% : 0.35 |
EPS(TTM) : 92.47 |
|
Book Value(₹) : 319.60 |
Market Cap(₹Cr) : 23,028.75 |
Face Value(₹) : 2.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 559.09 | 526.31 | 480.48 | 440.29 | 408.00 | 387.52 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 559.09 | 526.31 | 480.48 | 440.29 | 408.00 | 387.52 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 6.17 | 11.24 | 16.15 | 7.98 | 8.15 | 8.35 |
| Total Income | 565.26 | 537.55 | 496.63 | 448.27 | 416.15 | 395.87 |
| Total Expenditure | 489.20 | 445.56 | 399.79 | 396.85 | 355.46 | 407.01 |
| PBIDT | 76.06 | 91.99 | 96.84 | 51.42 | 60.69 | -11.14 |
| Interest | 0.67 | 0.72 | 0.68 | 0.33 | 0.34 | 0.11 |
| PBDT | 75.39 | 91.27 | 96.16 | 51.09 | 60.35 | -11.25 |
| Depreciation | 2.57 | 16.57 | 17.69 | 9.07 | 9.32 | 3.91 |
| Tax | 19.01 | 22.10 | 22.92 | 12.17 | 14.70 | 10.75 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.41 | -3.23 | -2.70 | -1.00 | -2.10 | -14.12 |
| Reported Profit After Tax | 54.22 | 55.83 | 58.25 | 30.85 | 38.43 | -11.79 |
| Extra-ordinary Items | -3.91 | -0.25 | -4.02 | -23.83 | 0.00 | -46.81 |
| Adjusted Profit After Extra-ordinary item | 58.13 | 56.08 | 62.27 | 54.68 | 38.43 | 35.02 |
| EPS (Unit Curr.) | 21.69 | 22.33 | 23.30 | 12.34 | 16.37 | -4.72 |
| EPS (Adj) (Unit Curr.) | 21.69 | 22.33 | 23.30 | 12.34 | 16.37 | -4.72 |
| Calculated EPS (Unit Curr.) | 21.69 | 22.33 | 23.30 | 12.34 | 15.37 | -4.72 |
| Calculated EPS (Adj) (Unit Curr.) | 21.69 | 22.33 | 23.30 | 12.34 | 15.37 | -4.72 |
| Calculated EPS (Ann.) (Unit Curr.) | 86.75 | 89.33 | 93.20 | 49.36 | 61.49 | -18.86 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 86.75 | 89.33 | 93.20 | 49.36 | 61.49 | -18.86 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 13.60 | 17.48 | 20.15 | 11.68 | 14.88 | -2.87 |
| PBDTM(%) | 13.48 | 17.34 | 20.01 | 11.60 | 14.79 | -2.90 |
| PATM(%) | 9.70 | 10.61 | 12.12 | 7.01 | 9.42 | -3.04 |